Raghu Kalluri
Company: Department of Cancer Biology The University of Texas MD Anderson Cancer Center
Job title: Professor & Chair
Seminars:
Live Panel Q&A – Ask the Speakers Your Burning Questions 10:40 am
day: Day One
Targeting Oncogenic KRAS-G12D Mutation Employing Engineered Exosomes in Pancreatic Cancer 9:25 am
Direct inhibitors do not exist for KRAS-G12D We engineered exosomes to deliver siRNA specific to Kras-G12D (iExosomes) The iExosomes target pancreatic cancer cells to suppress tumor growth and increase the overall survival of mice with PDAC Preclinical studies, GLP-toxicology studies, clinical grade GMP production and FDA IND filing led to a Phase I clinical trial…Read more
day: Day One